The Kinetix Group and Pfizer Health Equity Work Recognized by PM360

NEW YORK, NY — March 29, 2024 — The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer’s atopic dermatitis interactive guide for varying skin tones.

CKD Leaders Network Publishes New Thought Piece in Journal of Clinical Medicine

NEW YORK, NY — March 21, 2024 — In support of National Kidney Month, CKD Leaders Network, a Kinetix Group Network of Excellence dedicated to defining and spreading a best practice model for population health-driven chronic kidney disease (CKD) management, announced its new manuscript in the Journal of Clinical Medicine.

Petauri™ Acquires FORCE Communications

NASHVILLE, Tenn., Feb. 14, 2024 — Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations.

The Kinetix Group and White Swan Unveil AI-Powered Patient Centricity Program

NEW YORK, NY – January 30, 2024 – As part of an enduring partnership and shared commitment to improve the global care continuum, The Kinetix Group (TKG) and White Swan announced their new AI-Powered Patient Centricity Program.

PHLN Spotlight #7: Palliative Care Program with Optum Health

Optum Health created a program that involves providing guidance on how to discuss palliative care within an outpatient setting with the goal of improving the quality of life for patients and their families. To learn more about the Population Health Leaders Network (PHLN) and its work, please visit https://www.phlnetwork.org/